| 000 | 01401 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250516230636.0 | ||
| 264 | 0 | _c20150623 | |
| 008 | 201506s 0 0 eng d | ||
| 022 | _a1875-533X | ||
| 024 | 7 |
_a10.2174/0929867321666140815124246 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGarbayo, Elisa | |
| 245 | 0 | 0 |
_aDiagnostic and therapeutic uses of nanomaterials in the brain. _h[electronic resource] |
| 260 |
_bCurrent medicinal chemistry _c2014 |
||
| 300 |
_a4100-31 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aAlzheimer Disease _xdiagnosis |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aBlood-Brain Barrier _xmetabolism |
| 650 | 0 | 4 |
_aBrain Neoplasms _xdiagnosis |
| 650 | 0 | 4 |
_aCell-Penetrating Peptides _xchemistry |
| 650 | 0 | 4 |
_aDopamine Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aDrug Carriers _xchemistry |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aNanomedicine |
| 650 | 0 | 4 |
_aNanostructures _xchemistry |
| 650 | 0 | 4 |
_aNootropic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aParkinson Disease _xdiagnosis |
| 700 | 1 | _aEstella-Hermoso de Mendoza, Ander | |
| 700 | 1 | _aBlanco-Prieto, Maria J | |
| 773 | 0 |
_tCurrent medicinal chemistry _gvol. 21 _gno. 36 _gp. 4100-31 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2174/0929867321666140815124246 _zAvailable from publisher's website |
| 999 |
_c24113553 _d24113553 |
||